FindTrial
Sign In

Evaluation of TEWL (Trans Epidermal Water Loss) in Diabetic Patients

"Assessment of TEWL (Trans Epidermal Water Loss) in Foot of Diabetic Patients as a Predictor of Occurrence of Diabetic Foot Ulcer. - TEWL in DFU

Status
Unknown
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/034575
Enrollment
200
Registered
2021-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

AIIMSRishikesh
Lead Sponsor
ICRME Indiana University
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All patients with diagnosed Diabetes Mellitus

Exclusion criteria

Exclusion criteria: Patients with a healed or active Diabetic Foot Ulcer Patients who have had surgery for DFU Patients who have had previous surgical intervention in the foot for reasons other than DM

Design outcomes

Primary

MeasureTime frame
2 year/Development of diabetic ulcerTimepoint: Base line, 8 weeks, 16 weeks, 24 weeks, 32 weeks, 40 weeks, 48 weeks—

Secondary

MeasureTime frame
Measurement value of TEWL in various pressure areas of footTimepoint: Every eight weeks—

Countries

India

Contacts

Public ContactDr Akshay Kapoor

All India Institute of Medical Science,Rishikesh

debarati.psurg@aiimsrishikesh.edu.in9433834487

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026